Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ANADYS PHARMACEUTICALS INC | 75,000 | reported | 16 May 2007 | tx 1+75,000 |
| PMV Pharmaceuticals, Inc. | 33,500 | reported | 05 Jun 2025 | tx 12+323,000−161,500 |
| Atara Biotherapeutics, Inc. | 33,012 | reported | 10 Jun 2025 | tx 104+985,930−181,259 |
| Tempest Therapeutics, Inc. | 12,000 | reported | 22 Jun 2020 | tx 5+61,933 |
| Certara, Inc. | 7,059 | reported | 15 Jun 2021 | tx 1+7,059 |
| ANAPTYSBIO, INC | 6,000 | reported | 02 Feb 2018 | tx 5+85,296−64,296 |
| Turning Point Therapeutics, Inc. | 0 | reported | 17 Aug 2022 | tx 8+77,000−77,000 |
| Mirati Therapeutics, Inc. | 0 | reported | 23 Jan 2024 | tx 6+27,147−27,147 |
| Frazier Lifesciences Acquisition Corp | 0 | reported | 22 Nov 2022 | tx 1−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2025 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 7,828 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GIFT | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GIFT | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 07 Jun 2024 | GIFT | PMV Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 07 Jun 2024 | GIFT | PMV Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 31 Mar 2024 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 150,000 | 0.00 USD | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 6,808 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 7,555 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 12,784 | — | deriv |
| 29 Dec 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 6,808 | 58.75 USD | |
| 13 Nov 2023 | PURCHASE | Atara Biotherapeutics, Inc. | 179,020 | 0.22 USD | first after silence |
| 14 Nov 2023 | PURCHASE | Atara Biotherapeutics, Inc. | 90,980 | 0.31 USD | |
| 22 Jun 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 7,555 | 0.00 USD | |
| 22 Jun 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 12,784 | 0.00 USD | deriv |
| 08 Jun 2023 | GIFT | PMV Pharmaceuticals, Inc. | 21,500 | 0.00 USD | deriv |
| 08 Jun 2023 | GIFT | PMV Pharmaceuticals, Inc. | 21,500 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 21,500 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 57,000 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 79,500 | 0.00 USD | deriv |
| 22 Nov 2022 | EXERCISE | Frazier Lifesciences Acquisition Corp | 30,000 | — | deriv |
| 04 Nov 2022 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 39,000 | 0.00 USD | deriv |
| 05 Nov 2022 | GIFT | PMV Pharmaceuticals, Inc. | 39,000 | 0.00 USD | deriv |
| 05 Nov 2022 | GIFT | PMV Pharmaceuticals, Inc. | 39,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Nov 2023.